Esperion Therapeutics
ESPR
#6376
Rank
NZ$1.34 B
Marketcap
NZ$5.63
Share price
-4.51%
Change (1 day)
73.27%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -NZ$49.04 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are NZ$0.30 Billion. In 2024 the company made an earning of NZ$12.46 Million, an increase over its 2023 earnings that were of -NZ$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$49.04 Million-493.29%
2024 NZ$12.46 M-104.99%
2023 -NZ$0.25 Billion-15.03%
2022 -NZ$0.3 Billion-20.61%
2021 -NZ$0.37 Billion84.28%
2020 -NZ$0.21 Billion35.75%
2019 -NZ$0.15 Billion-55.71%
2018 -NZ$0.34 Billion19.57%
2017 -NZ$0.28 Billion125.39%
2016 -NZ$0.13 Billion51.43%
2015 -NZ$81.83 Million36.45%
2014 -NZ$59.98 Million43.55%
2013 -NZ$41.78 Million145.26%
2012 -NZ$17.04 Million
2002 -NZ$48.57 Million-7.81%
2001 -NZ$52.68 Million15.03%
2000 -NZ$45.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$19.68 B-43,290.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$8.54 B-18,849.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.87 Billion 1,790.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.12 Billion 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$8.27 M-118.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.12 B-2,575.39%๐Ÿ‡บ๐Ÿ‡ธ USA